Important mammalian veterinary viral immunodiseases and their control (Q37977256)

26 August 2017

Important mammalian veterinary viral immunodiseases and their control (English)

1 reference

26 August 2017

J R Patel

1

1 reference

26 August 2017

J G M Heldens

series ordinal

2

1 reference

26 August 2017

T Bakonyi

series ordinal

3

1 reference

26 August 2017

M Rusvai

series ordinal

4

1 reference

26 August 2017

language of work or name

English

0 references

publication date

17 January 2012

1 reference

26 August 2017

1 reference

26 August 2017

30

1 reference

26 August 2017

1767-1781

1 reference

26 August 2017

10

1 reference

Viruses can cause disease in the absence of morphological evidence of cell injury: implication for uncovering new diseases in the future

26 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Human Fibroblasts Infected with Rubella Virus Produce a Growth Inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Virus-induced acquired immune suppression by cytotoxic T cell-mediated immunopathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Biology and pathogenesis of lentiviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Animal immunodeficiency viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Immune mechanisms in the pathogenesis of viral diseases: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

A perspective on equine infectious anemia with an emphasis on vector transmission and genetic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

The comparative pathology of the lentiviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

HIV/AIDS in China. Vaccine development with a distinctly Chinese flavor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

A proviral derivative from a reference attenuated EIAV vaccine strain failed to elicit protective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

EIAV envelope diversity: shaping viral persistence and encumbering vaccine efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Envelope variation as a primary determinant of lentiviral vaccine efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Divergence, not diversity of an attenuated equine lentivirus vaccine strain correlates with protection from disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Cytotoxic T lymphocytes in protection against equine infectious anemia virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Transient suppression of equine immune responses by equine infectious anemia virus (EIAV).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Antigenic variation in visna virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Genomic changes associated with antigenic variation of visna virus durig persistent infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Immunization with a recombinant envelope protein (rgp90) of EIAV produces a spectrum of vaccine efficacy ranging from lack of clinical disease to severe enhancement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Routes of transmission and consequences of small ruminant lentiviruses (SRLVs) infection and eradication schemes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Transmission of small ruminant lentiviruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Prevention strategies against small ruminant lentiviruses: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Transmission and control implications of seroconversion to Maedi-Visna virus in Basque dairy-sheep flocks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Maternal factors associated with prenatal transmission of ovine lentivirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Maedi-visna control in sheep III: Results and evaluation of a voluntary control program in the Netherlands over a period of four years

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

7 January 2021

12 December 2020

Chronic Arthritis in Goats Caused by a Retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Infection of dendritic cells by the Maedi-Visna lentivirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Pathogenesis of lentivirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

The pathogenesis of slow virus infections: molecular analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Slow Virus Replication: the Role of Macrophages in the Persistence and Expression of Visna Viruses of Sheep and Goats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

CD4(+) T-cells are required for the establishment of maedi-visna virus infection in macrophages but not dendritic cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Regulation of the visna virus long terminal repeat in macrophages involves cellular factors that bind sequences containing AP-1 sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

TNFalpha and GM-CSF-induced activation of the CAEV promoter is independent of AP-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Localization of a TNF-activated transcription site and interactions with the gamma activated site within the CAEV U3 70 base pair repeat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Plasmid DNA encoding caprine interferon gamma inhibits antibody response to caprine arthritis-encephalitis virus (CAEV) surface protein encoded by a co-administered plasmid expressing CAEV env and tat genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Prime-boost vaccination with plasmid DNA encoding caprine-arthritis encephalitis lentivirus env and viral SU suppresses challenge virus and development of arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

The effect of post-infection immunization on the severity of experimental visna

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Vaccination with a T-cell-priming Gag peptide of caprine arthritis encephalitis virus enhances virus replication transiently in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Current thoughts on feline immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Feline immunodeficiency. ABCD guidelines on prevention and management.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Transmission and immunopathogenesis of FIV in cats as a model for HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Characterization of two monoclonal antibodies against feline immunodeficiency virus gag gene products and their application in an assay to evaluate neutralizing antibody activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Preferential feline immunodeficiency virus (FIV) infection of CD4+ CD25+ T-regulatory cells correlates both with surface expression of CXCR4 and activation of FIV long terminal repeat binding cellular transcriptional factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Feline immunodeficiency virus infection phenotypically and functionally activates immunosuppressive CD4+CD25+ T regulatory cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Vaccination against the feline immunodeficiency virus: the road not taken

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Effect of dual-subtype vaccine against feline immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Efficacy and safety of a feline immunodeficiency virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Dual-subtype feline immunodeficiency virus vaccine provides 12 months of protective immunity against heterologous challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Limited efficacy of an inactivated feline immunodeficiency virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Advances in FIV vaccine technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Review of companion animal viral diseases and immunoprophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Immunogenicity of an anti-clade B feline immunodeficiency fixed-cell virus vaccine in field cats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Feline leukaemia. ABCD guidelines on prevention and management.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Identification of a cellular cofactor required for infection by feline leukemia virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Feline leukemia virus: current status of the feline induced immune depression and immunoprevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Clinical and immunologic aspects of FeLV-induced immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Comparative studies of the efficacy of a recombinant feline leukaemia virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Feline leukaemia virus and vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Pathogenesis of aleutian mink disease parvovirus and similarities to b19 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

The pathogenesis of Aleutian disease of mink. I. In vivo viral replication and the host antibody response to viral antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Aleutian Disease Virus in B and T Lymphocytes from Blood and Spleen and in Bone Marrow Cells from Naturally Infected Mink

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Replication of Aleutian disease virus in mink lymphocytes infected in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Antigen distribution in organs of mink with Aleutian disease parvovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Immunological enhancement and the pathogenesis of dengue haemorrhagic fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Identification of aleutian mink disease parvovirus capsid sequences mediating antibody-dependent enhancement of infection, virus neutralization, and immune complex formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Suppression of lipopolysaccharide-induced antiviral transcription factor (STAT-1 and NF-kappa B) complexes by antibody-dependent enhancement of macrophage infection by Ross River virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Suppression of antiviral responses by antibody-dependent enhancement of macrophage infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Acute interstitial pneumonia in mink kits: experimental reproduction of the disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

DNA vaccination with the Aleutian mink disease virus NS1 gene confers partial protection against disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Vaccination with Aleutian mink disease parvovirus (AMDV) capsid proteins enhances disease, while vaccination with the major non-structural AMDV protein causes partial protection from disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Involvement of morbilliviruses in the pathogenesis of demyelinating disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Lymphocyte responsiveness to lectin and myelin antigens in canine distemper infection in relation to the development of demyelinating lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Pathogenesis and immunopathology of systemic and nervous canine distemper

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Immunohistochemical demonstration of the putative canine distemper virus receptor CD150 in dogs with and without distemper

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Immunodeficiencies caused by infectious diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Canine distemper virus uses both the anterograde and the hematogenous pathway for neuroinvasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Demyelination in canine distemper virus infection: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Studies on the intrathecal humoral immune response in canine distemper encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Morbillivirus infections, with special emphasis on morbilliviruses of carnivores

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Identification of virus causing recent seal deaths

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Canine distemper antibodies in lions of the Masai Mara.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Malignant catarrhal fever caused by ovine herpesvirus-2 in pigs in Norway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Epizootic malignant catarrhal fever in three bison herds: differences from cattle and association with ovine herpesvirus-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Recovery of a herpesvirus from a roan antelope (Hippotragus equinus).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Recognition of another member of the malignant catarrhal fever virus group: an endemic gammaherpesvirus in domestic goats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Mural folliculitis and alopecia caused by infection with goat-associated malignant catarrhal fever virus in two sika deer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Malignant catarrhal fever in free-ranging cervids associated with OvHV-2 and CpHV-2 DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Blue wildebeest and the aetiological agent of bovine malignant catarrhal fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Identification of ovine herpesvirus-2 infection in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Malignant catarrhal fever: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Experimental infection of sheep with ovine herpesvirus 2 via aerosolization of nasal secretions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Experimental aerosol infection of cattle (Bos taurus) with ovine herpesvirus 2 using nasal secretions from infected sheep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Diseases of humans and their domestic mammals: pathogen characteristics, host range and the risk of emergence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Maasai perception of the impact and incidence of malignant catarrhal fever (MCF) in southern Kenya

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Characterisation of the lymphoproliferation in rabbits experimentally affected with malignant catarrhal fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

The vascular lesions of a cow and bison with sheep-associated malignant catarrhal fever contain ovine herpesvirus 2-infected CD8(+) T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

The detection and behaviour of the herpesvirus of malignant catarrhal fever in bovine lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

The detection of Alcelaphine herpesvirus-1 DNA by in situ hybridization of tissues from rabbits affected with malignant catarrhal fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

CD8(+)/perforin(+)/WC1(-) gammadelta T cells, not CD8(+) alphabeta T cells, infiltrate vasculitis lesions of American bison (Bison bison) with experimental sheep-associated malignant catarrhal fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Malignant catarrhal fever induced by alcelaphine herpesvirus 1 is associated with proliferation of CD8+ T cells supporting a latent infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Ex vivo bioluminescence detection of alcelaphine herpesvirus 1 infection during malignant catarrhal fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Antibodies to malignant catarrhal fever virus in sheep sera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Antibodies to malignant catarrhal fever virus in cattle with non-wildebeest-associated malignant catarrhal fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Attemps to immunize cattle against virulent African malignant catarrhal fever virus (alcelephine herpesvirus-1) with a herpesvirus isolated from American cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

An immunisation strategy for the protection of cattle against alcelaphine herpesvirus-1-induced malignant catarrhal fever.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

The prevalence of types I and II feline coronavirus infections in cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

A comparison of lymphatic tissues from cats with spontaneous feline infectious peritonitis (FIP), cats with FIP virus infection but no FIP, and cats with no infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Isolation and identification of feline peritoneal macrophages for in vitro studies of coronavirus-macrophage interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Feline infectious peritonitis. ABCD guidelines on prevention and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Protection against feline infectious peritonitis by intranasal inoculation of a temperature-sensitive FIPV vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Placebo-controlled evaluation of a modified life virus vaccine against feline infectious peritonitis: safety and efficacy under field conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Live, attenuated coronavirus vaccines through the directed deletion of group-specific genes provide protection against feline infectious peritonitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Dendritic cells--at the front-line of pathogen attack

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

N(pro) of classical swine fever virus is an antagonist of double-stranded RNA-mediated apoptosis and IFN-alpha/beta induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Modulation of immune cell populations and activation markers in the pathogenesis of African swine fever virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

African swine fever: a disease characterized by apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

The pathogenesis of African swine fever in the resistant bushpig

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

African swine fever virus proteins involved in evading host defence systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Apoptosis in lymph nodes in acute African swine fever.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Characterization of pathogenic and non-pathogenic African swine fever virus isolates from Ornithodoros erraticus inhabiting pig premises in Portugal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

In vivo depletion of CD8+ T lymphocytes abrogates protective immunity to African swine fever virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Functional and immunological properties of the baculovirus-expressed hemagglutinin of African swine fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

The African swine fever virus proteins p54 and p30 are involved in two distinct steps of virus attachment and both contribute to the antibody-mediated protective immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Neutralizing antibodies to African swine fever virus proteins p30, p54, and p72 are not sufficient for antibody-mediated protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Differentiation of types 1a, 1b and 2 bovine viral diarrhoea virus (BVDV) by PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Fatal bovine viral diarrhoea virus infection of adult cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Severe disease in adult dairy cattle in three UK dairy herds associated with BVD virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Prevention of transplacental infection of bovine foetus by bovine viral diarrhoea virus through vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Experimental production of fatal mucosal disease in cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Immunoprophylaxis against important virus disease of horses, farm animals and birds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Veterinary vaccine development from an industrial perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Bovine Leukemia Virus Genes in the DNA of Leukemic Cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Immunocompetence of sheep experimentally infected with bovine leukemia virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Antigenic variation and lentivirus persistence: variations in envelope gene sequences during EIAV infection resemble changes reported for sequential isolates of HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Long terminal repeat sequences of equine infectious anaemia virus are a major determinant of cell tropism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

Serological comparison among various strains of equine infectious anemia virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

7 January 2021

Early events in immune evasion by the lentivirus maedi-visna occurring within infected lymphoid tissue.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

7 January 2021

The visna virus long terminal repeat directs expression of a reporter gene in activated macrophages, lymphocytes, and the central nervous systems of transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

7 January 2021

Priming with tat-deleted caprine arthritis encephalitis virus (CAEV) proviral DNA or live virus protects goats from challenge with pathogenic CAEV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

7 January 2021

Frequent perinatal transmission of feline immunodeficiency virus by chronically infected cats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

7 January 2021

In vivo lymphocyte tropism of feline immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

7 January 2021

Proviral burden and infection kinetics of feline immunodeficiency virus in lymphocyte subsets of blood and lymph node

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

7 January 2021

Induction of feline immunodeficiency virus-specific cytolytic T-cell responses from experimentally infected cats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

7 January 2021

Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

7 January 2021

Aleutian Disease of Mink

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

7 January 2021

Pathogenesis of aleutian disease of mink: identification of nonpersistent infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

7 January 2021

Aleutian mink disease parvovirus infection of mink macrophages and human macrophage cell line U937: demonstration of antibody-dependent enhancement of infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

7 January 2021

Lymphocyte-mediated immune cytotoxicity in dogs infected with virulent canine distemper virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

7 January 2021

Macrophage Fc receptors control infectivity and neutralization of canine distemper virus-antibody complexes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

7 January 2021

Newly recognized herpesvirus causing malignant catarrhal fever in white-tailed deer (Odocoileus virginianus)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

7 January 2021

Feline coronavirus type II strains 79-1683 and 79-1146 originate from a double recombination between feline coronavirus type I and canine coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

7 January 2021

Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

7 January 2021

Immunology of bovine viral diarrhea virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.014

7 January 2021

Pathogenesis of 'sheep-associated' malignant catarrhal fever in rabbits

1 reference

12 December 2020

Derivation of a DNA clone corresponding to the viral agent of sheep-associated malignant catarrhal fever

1 reference

12 December 2020

Importance of ewe/lamb relationship and breed in the epidemiology of maedi-visna virus infections

1 reference

12 December 2020

Activation of caprine arthritis-encephalitis virus expression during maturation of monocytes to macrophages

1 reference

12 December 2020

Feline immunodeficiency virus: a neurotropic lentivirus

1 reference

12 December 2020

Maedi-visna virus infection in sheep: a review

1 reference

12 December 2020

Randomized blind trial of a commercial FeLV vaccine

1 reference

12 December 2020

Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus

1 reference

12 December 2020

Immunisation of cattle against the herpesvirus of malignant catarrhal fever: failure of inactivated culture vaccines with adjuvant

1 reference

12 December 2020

Antigenic drift of equine infectious anemia virus in chronically infected horses

1 reference

12 December 2020

Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines

1 reference

12 December 2020

Feline infectious peritonitis: experimental evidence for its multiphasic nature.

1 reference

12 December 2020

Identification of viral antigens that induce antibody responses on exposure to coronaviruses

1 reference

12 December 2020

Pathogenesis of canine distemper.

1 reference

12 December 2020

Malignant catarrhal fever: experimental transmission of the 'sheep-associated' form of the disease from cattle and deer to cattle, deer, rabbits and hamsters

1 reference

12 December 2020

Acute arthritis in caprine arthritis-encephalitis virus challenge exposure of vaccinated or persistently infected goats

1 reference

12 December 2020

Equine infectious anemia: current knowledge

1 reference

12 December 2020

Primary stage of feline immunodeficiency virus infection: viral dissemination and cellular targets

1 reference

12 December 2020

Vaccination with a feline immunodeficiency virus multiepitopic peptide induces cell-mediated and humoral immune responses in cats, but does not confer protection

1 reference

12 December 2020

Ovine lentivirus is macrophagetropic and does not replicate productively in T lymphocytes

1 reference

12 December 2020

DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies

1 reference

12 December 2020

Aleutian mink disease: puzzles and paradigms.

1 reference

12 December 2020

Experimental infection of warthos (Phacochoerus aethiopicus) with African swine fever virus.

1 reference

12 December 2020

Ovine lentivirus expression and disease. Virus replication, but not entry, is restricted to macrophages of specific tissues

1 reference

12 December 2020

Much of the increased IgG in Aleutian disease of mink is viral antibody

1 reference

12 December 2020

Isolation and characterization of circulating feline leukemia virus-immune complexes from plasma of persistently infected pet cats removed by ex vivo immunosorption

1 reference

12 December 2020

An apparently new transmissible disease of cattle.

1 reference

12 December 2020

STATISTICAL SURVEY OF ALEUTIAN DISEASE IN RANCH MINK.

1 reference

12 December 2020

Immunofluorescent localization of equine infectious anemia virus in tissue.

1 reference

12 December 2020

Comparison of the efficacy of three commercial feline leukemia virus vaccines in a natural challenge exposure

1 reference

12 December 2020

Studies on equine infectious anemia virus transmission by insects

1 reference

12 December 2020

Coinfection with bovine viral diarrhea virus and Mycoplasma bovis in feedlot cattle with chronic pneumonia.

1 reference

12 December 2020

Feline leukaemia viruses: molecular biology and pathogenesis.

1 reference

12 December 2020

Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats.

1 reference

12 December 2020

Apoptosis and T-cell depletion during feline infectious peritonitis

1 reference

12 December 2020

The protection of rabbits against the herpesvirus of malignant catarrhal fever by inactivated vaccines

1 reference

12 December 2020

Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages

1 reference

12 December 2020

Equine infectious anemia virus: immunopathogenesis and persistence

1 reference

12 December 2020

Myelin-Specific Autoantibodies Associated with Central Nervous System Demyelination in Canine Distemper Virus Infection

1 reference

12 December 2020

Mechanisms contributing to the virus persistence in Aleutian disease.

1 reference

12 December 2020

Transmission of ovine herpesvirus 2 in lambs

1 reference

12 December 2020

Symposium on the mucosal disease complex. II. Pathology of a mucosal disease of cattle

1 reference

12 December 2020

Experimental canine distemper virus-induced demyelination.

1 reference

12 December 2020

10.1016/J.VACCINE.2012.01.014

Identifiers

DOI

1 reference

release_xfxb5eadrbe4xi4ihdffokzwj4

26 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xfxb5eadrbe4xi4ihdffokzwj4

24 November 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/xfxb5eadrbe4xi4ihdffokzwj4

24 November 2022

mapped directly with Wikidata item

1 reference